Cargando…

Impact of Orlistat-Induced Weight Loss on Diastolic Function and Heart Rate Variability in Severely Obese Subjects with Diabetes

Objective. Determine the impact of Orlistat-induced weight loss on metabolic profile and cardiovascular function in severely obese patients with type 2 diabetes. Methods. Twenty-nine patients were randomized either to a nonplacebo control group or to a treatment group with Orlistat thrice a day. Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Julie, Paquette, Carmen, Marceau, Simon, Hould, Frédéric-Simon, Lebel, Stéfane, Simard, Serge, Dumesnil, Jean-Gaston, Poirier, Paul
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021886/ https://www.ncbi.nlm.nih.gov/pubmed/21253512 http://dx.doi.org/10.1155/2011/394658

Ejemplares similares

Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
por: Woods, Philippe, et al.
Publicado: (2004)

Current Outcomes of Laparoscopic Duodenal Switch
por: Biertho, Laurent, et al.
Publicado: (2016)

Body mass index is associated with epigenetic age acceleration in the visceral adipose tissue of subjects with severe obesity
por: de Toro-Martín, Juan, et al.
Publicado: (2019)

Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
por: Turcot, Valérie, et al.
Publicado: (2013)

Methylation quantitative trait loci within the TOMM20 gene are associated with metabolic syndrome-related lipid alterations in severely obese subjects
por: de Toro-Martín, Juan, et al.
Publicado: (2016)

Characterization of Dedifferentiating Human Mature Adipocytes from the Visceral and Subcutaneous Fat Compartments: Fibroblast-Activation Protein Alpha and Dipeptidyl Peptidase 4 as Major Components of Matrix Remodeling
por: Lessard, Julie, et al.
Publicado: (2015)

Taking Orlistat: Predicting Weight Loss over 6 Months
por: Hollywood, Amelia, et al.
Publicado: (2011)

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin
por: Pamuk, Baris, et al.
Publicado: (2018)

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose
por: Grudén, Stefan, et al.
Publicado: (2021)

Acute and chronic effect of bariatric surgery on circulating autotaxin levels
por: Bourgeois, Raphaëlle, et al.
Publicado: (2019)

Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007)

Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
por: Svendsen, Mette, et al.
Publicado: (2011)

Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008)

Macrocytic Anemia and Thrombocytopenia Induced by Orlistat
por: Palacios-Martinez, David, et al.
Publicado: (2013)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial
por: Holmbäck, Ulf, et al.
Publicado: (2022)

Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates
por: Kumar, Pratap, et al.
Publicado: (2014)

Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study
por: Anagnostis, Panagiotis, et al.
Publicado: (2012)

Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011)

The Effect of Orlistat on Sterol Metabolism in Obese Patients
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting
por: Feigenbaum, Amiel, et al.
Publicado: (2005)

Molecular remodeling of adipose tissue is associated with metabolic recovery after weight loss surgery
por: Bouchard-Mercier, Annie, et al.
Publicado: (2022)

DUSP1 Gene Polymorphisms Are Associated with Obesity-Related Metabolic Complications among Severely Obese Patients and Impact on Gene Methylation and Expression
por: Guénard, F., et al.
Publicado: (2013)

High Sensitivity of Giardia duodenalis to Tetrahydrolipstatin (Orlistat) In Vitro
por: Hahn, Juliane, et al.
Publicado: (2013)

Orlistat-Induced Gut Microbiota Modification in Obese Mice
por: Ke, Jing, et al.
Publicado: (2020)

IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery
por: Faramia, Justine, et al.
Publicado: (2021)

Clinical and economic considerations of antiobesity treatment: a review of orlistat
por: Zohrabian, Armineh
Publicado: (2010)

Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase
por: Fako, Valerie E., et al.
Publicado: (2014)

An Unexpected Result of Obesity Treatment: Orlistat-Related Acute Pancreatitis
por: Kose, Murat, et al.
Publicado: (2015)

The Application of Quantitative (1)H-NMR for the Determination of Orlistat in Tablets
por: Sun, Shanshan, et al.
Publicado: (2017)

Selection of orlistat as a potential inhibitor for lipase from Candida species
por: Khedidja, Benarous, et al.
Publicado: (2011)

Risk of colorectal cancer after initiation of orlistat: matched cohort study
por: Hong, Jin-Liern, et al.
Publicado: (2013)

Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance
por: Kim, Dae Hun, et al.
Publicado: (2018)

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan
por: Syed, Asghar Hussain, et al.
Publicado: (2020)

The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case Report
por: Jarrett, Zachary S., et al.
Publicado: (2021)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review
por: Hao, Xiaoqing, et al.
Publicado: (2023)

Correlation between diastolic seismocardiography variables and echocardiography variables( )
por: Agam, Ahmad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btqij0f25scl22e0b34c16oau6